UroGen Pharma Ltd.

URGN · NASDAQ
Analyze with AI
$23.04+$1.32 (+6.06%)
At close:Dec 19, 2025, 5:24 PM UTC
$23.04+$0.00 (+0%)
After hours:Dec 19, 2025, 5:24 PM UTC
P/E TTM-7.1
P/B TTM-11.78
P/S TTM11.44
Dividend Yield0%
EPS-$3.35
Beta1.225
Valuation
PEG Ratio1.61
FCF Yield-11.46%
EV / EBITDA-9.45
More On Valuation »
Quality
ROIC-77.63%
Gross Margin88.54%
Cash Conv. Ratio0.79
More On Quality »
Growth
Revenue 3Y CAGR11.99%
FCF Growth-26.76%
More On Growth »
Safety
Net Debt / EBITDA-0.28
Interest Coverage-5.14
More On Safety »
Efficiency
Inventory Turnover1.52
Cash Conv. Cycle-141.33
More On Efficiency »

UroGen Pharma Ltd. (URGN) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is UroGen Pharma Ltd. (URGN) stock price today?

As of Dec 19, 2025, 5:24 PM UTC, UroGen Pharma Ltd. (URGN) stock is trading at $23.04. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date URGN stock quotes for informed trading decisions.

What is UroGen Pharma Ltd.'s market capitalization?

UroGen Pharma Ltd. (URGN) has a market capitalization of approximately $1.1B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare UroGen Pharma Ltd.'s size relative to other companies in the USD market. The market cap figure updates automatically as the URGN stock price changes.

What is the 52-week range for UroGen Pharma Ltd. stock?

UroGen Pharma Ltd. (URGN) stock has traded in a 52-week range of $3.42 — $30.00. The 52-week range shows the highest and lowest prices at which URGN traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current UroGen Pharma Ltd. stock price to this range provides context for recent price action.

How much trading volume does UroGen Pharma Ltd. stock have?

UroGen Pharma Ltd. (URGN) stock recently traded approximately 171.8K shares. Trading volume indicates market liquidity and investor interest in URGN. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting UroGen Pharma Ltd. stock.

Does UroGen Pharma Ltd. pay dividends to shareholders?

Yes, UroGen Pharma Ltd. (URGN) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate UroGen Pharma Ltd. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is UroGen Pharma Ltd.'s intraday price range?

Today, UroGen Pharma Ltd. (URGN) stock has traded in a range of $21.72 — $23.18. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring URGN's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get UroGen Pharma Ltd. stock data?

AlphaPilot sources real-time URGN stock quotes, fundamental financial data, and historical price charts for UroGen Pharma Ltd. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The UroGen Pharma Ltd. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of URGN stock performance.